These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2123035)

  • 1. Thrombolytic therapy in acute MI. Weighing the risks and benefits.
    Ro KG; Anderson HV
    Postgrad Med; 1990 Dec; 88(8):79-80, 83-6, 89-90 passim. PubMed ID: 2123035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy for myocardial infarction.
    Guerci AD
    Md Med J; 1990 Apr; 39(4):377-81. PubMed ID: 2110282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW; Zeitler R; Fitzpatrick P
    Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of thrombolytic treatment for myocardial infarction: comparison of anistreplase, alteplase and streptokinase in 270 patients treated within 4 hours.
    Machecourt J; Dumoulin J; Calop J; Foroni L; Terisse MP; Henon T; Vanzetto G; Denis B; Bassand JP; Cassagnes J
    Eur Heart J; 1993 Jan; 14(1):75-83. PubMed ID: 8432296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The choice of appropriate thrombolytic agents as therapy in acute heart infarct].
    Görge G; Meyer J
    Med Klin (Munich); 1992 Feb; 87(2):70-80, 108. PubMed ID: 1542286
    [No Abstract]   [Full Text] [Related]  

  • 6. An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.
    Baxter-Jones CS; White HD; Anderson JL
    J Interv Cardiol; 1993 Mar; 6(1):15-23. PubMed ID: 10171637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of aspirin with thrombolytic therapy in acute myocardial infarction.
    Hennekens CH
    Chest; 1990 Apr; 97(4 Suppl):151S-155S. PubMed ID: 2108852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic treatment of myocardial infarction. Agents, indications, complications].
    Curyło AM
    Przegl Lek; 1992; 49(9):312-4. PubMed ID: 1302358
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolytics.
    Ostrow CL
    AACN Clin Issues Crit Care Nurs; 1992 May; 3(2):423-36. PubMed ID: 1576039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 12. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current issues concerning thrombolytic therapy for acute myocardial infarction.
    Hennekens CH; O'Donnell CJ; Ridker PM; Marder VJ
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):18S-22S. PubMed ID: 7775709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy.
    Jafri SM; Walters BL; Borzak S
    J Intensive Care Med; 1995; 10(2):54-63. PubMed ID: 10172420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolytic therapy for acute myocardial infarction--round 2.
    Lancet; 1988 Mar; 1(8585):565-7. PubMed ID: 2894496
    [No Abstract]   [Full Text] [Related]  

  • 17. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After ISIS-3.
    Hannaford PC; Kay CR
    Lancet; 1992 May; 339(8803):1225; author reply 1226-7. PubMed ID: 1349950
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy: then and now.
    Cole PL
    Heart Lung; 1991 Sep; 20(5 Pt 2):542-51. PubMed ID: 1910023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.